In 2025, the company reported a +2.39% YoY growth in revenue, reflecting portfolio concentration: Biktarvy ($14.33B) continues to dominate the HIV segment with strong patient uptake, Descovy ($2.75B) remains a key contributor in both treatment and prevention, while Genvoya ($1.49B) continues its gradual decline as patients transition to newer regimens highlighting a shift within its HIV portfolio
Participants began at a 2 mg starting dose and stepped up roughly every four weeks toward their assigned target
Our Organic Moringa Drops come in a liquid form
For many GLP-1 users, the psychological changes are as powerful as the physical changes
Baked salmon with roasted vegetables Protein: 34g | Calories: 420 | Prep time: 25 minutes Season a five-ounce salmon fillet with lemon, dill, and a pinch of salt
MyPlan GLP-1 Companion A protein floor to clear Your dose week: A generic tracker Not part of the picture